Journals / Erciyes Tıp Dergisi / 2007 / Cilt: 29 - Sayı: 5

Recurrent glioblastoma multiforme: A case report

Nüks glioblastoma multiforme: Bir olgu sunumu

Pages
428–432
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Imaging studies for differantion of recurrence and brain necrosis was discussed in this article.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Glioblastoma multiforme is the most frequent primary malignant brain tumor in adults.
📊
Key Findings & Data:In this case report, we present a patient with grade II astrocytoma that recurred as grade IV astrocytoma (Glioblastoma multiforme) 3 months after first resection.
💡
Conclusion & Impact:Imaging studies for differantion of recurrence and brain necrosis was discussed in this article.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Glioblastoma multiforme is the most frequent primary malignant brain tumor in adults. Standard therapy consists of surgical resection to the extent that is safely feasible, followed by radiotherapy. Major problem after therapy is local failure. In this case report, we present a patient with grade II astrocytoma that recurred as grade IV astrocytoma (Glioblastoma multiforme) 3 months after first resection. Postoperative chemoradiotherapy with temozolomide was administered to the patient. After progression of disease, temozolomide was given to the patient. Imaging studies for differantion of recurrence and brain necrosis was discussed in this article.

Özet

Glioblastoma multiforme erişkinde en sık görülen malign primer beyin tümörüdür. Standart tedavi yaklaşımı mümkün olduğu kadar cerrahi rezeksiyon sonrası RT uygulamasıdır. Glioblastoma multiformenin tedavi sonrasi izlemde en sık karşılaşılan problem lokal kontrolün sağlanamamasıdır. Bu makalede opere grade II astrositoma iken 3 ayda nüks ederek grade IV astrositomaya (Glioblastoma multiforme) malign transformasyon gösteren, postoperatif temozolomidle kemoradyoterapi uygulandiktan kisa sure sonra nüks eden, temozolomide tedavisine devam edilen, 31 yaşında erkek olgunun uzun sağkalımı ile nüks ve radyasyon nekrozu arasmdaki görüntüleme yöntemleri benzerlikleri ve ayırıcı tanıdaki güçlükler literatür eşliğinde tartışıldı.

🔖

Cite This Article

GÜNDOĞ, M., ORHAN, O., KURTSOY, A., SOYUER, S., YILDIZ, O. G., EROĞLU, C., DURAK, A. C., KAPLAN, B. (2022). Recurrent glioblastoma multiforme: A case report. Erciyes Tıp Dergisi, Cilt: 29 - Sayı: 5, 428–432. https://ajindex.com/articles/502757

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Abacıoğlu U, Çetin İ, Akgün Z, ve ark. Erişkin glioblastoma multiforme tanılı hastalarda radyoterapi sonuçları ve prognostik faktörler. Türk Onkoloji Dergisi 2004;19:112-118
  2. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;10:987-996
  3. Bıkmaz K, İplikçioğlu AC, Gökduman C, ve ark. Serebral radyasyon nekrozu. Türk Nöroşirurji Dergisi 2004;14:77-83
  4. Hu JQ, Guan YH, Zhao LZ, et al. Delayed radiation encephalopathy after radiotherapy for nasopharyngeal cancer; A CT study of 45 cases. J Comput Assist Tomogr 1991;15:181-187
  5. Doyle WK, Budinger TF, Valk PE, et al. Differentiation of cerebral adiation necrosis from tumor recurrence by 18f FDG and 82Rb positron emission tomography. J Comput Assist Tomogr 1987;11:563-570
  6. Newlands ES, Blackledge GR, Slack JA, et al: Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856). Br J Cancer 1992;65: 287-291
  7. Stupp R, Ostermann S, Leyvraz S, et al: Cerebrospinal fluid levels of temozolomide as a surrogate marker for brain penetration. Proc Am Soc Clin Oncol 2001;20:59a
  8. Brada M, Hoang-Xuan K, Rampling R, et al: Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. Ann Oncol 2001;12:259-266
  9. Tunç E, Ünsal, Öztürk AS, ve ark. Yüksek grade’li beyin tümörü tanısıyla radyoterapi uygulanan hastalarda tedavi sonuçları: retrospektif değerlendirme. Türk Hematoloji-Onkoloji Dergisi 2005;15:18-28
  10. Salcman M. Glioblastoma multiforme and anaplastic astrocytoma. In: Kaye AH, Laws ER, editors. Brain Tumors: An encyclopedic approch. 2nd ed. London; Churchill Livinstone; 2001. p. 493-523
  11. Topuz E, Aydıner A, Karadeniz AN. Klinik Onkoloji. Karadeniz AN: Santral Sinir Sistemi ve Hipofiz Tümörleri. İstanbul Üniversitesi Onkoloji Enstitüsü Yayınları:06, İstanbul; 2000;201-226
  12. Lee AWM, Cheng LOC. Magnetic Resonance Imaging in the clinical diagnosis of late temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma. Clinical Radiology 1990;42:24-31
  13. Chang VFH, Rumpel H, AW YS, et al. Temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma; H MR Spectroscopic Findings. Int. J Radiation Oncology Biol. Phys 1999;45:699-705
  14. Ott D, Hennig J, Enst T. Human Brain Tumors; assesment with in vivo proton MR spectroscopy. Radiology 1993;186:745-752
  15. Lorberboym M, Mandell LR, Mosesson RE. The role of thallium-201-uptake and